drugset / Trial / NCT05418465
Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic Nephropathy
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective, open, multicenter clinical trial.The objective of this study is to evaluate the efficacy and safety of Huangqi Guizhi Wuwu Decoction in patients with CKD stage 2-4 diabetic nephropathy.
Timeline
- Start
- 2022-01-26
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Huangqi Guizhi Wuwu decoction | Traditional medicine (herbal / TCM) | 100 ml | Oral |